本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Repare Therapeutics Inc.

1.43
+0.07005.15%
盤後1.38-0.0475-3.32%17:05 EDT
成交量:31.93萬
成交額:45.44萬
市值:6,079.03萬
市盈率:-0.72
高:1.45
開:1.39
低:1.37
收:1.36
資料載入中...
2021/05/14

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/08

重要事件披露

8-K - Current report
2021/04/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/04

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/04

重要事件披露

8-K - Current report
2021/03/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/13

重要事件披露

8-K - Current report
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/07

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership